Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Dupilumab helps children with alopecia areata regrow hair safely.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Methotrexate plus prednisolone had the fewest serious side effects.

Clofazimine effectively treated ashy dermatosis in a patient.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Baricitinib is the most effective treatment for alopecia areata.

Anti-TNF therapy can cause hair loss and skin issues.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Treating generalized granuloma annulare is difficult, with PUVA being the most effective option, but relapses are common.

Belatacept may be a promising treatment for alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.